Skip to main content
Top
Published in: Supportive Care in Cancer 1/2016

01-01-2016 | Original Article

Clinical predictors of aspiration after esophagectomy in esophageal cancer patients

Authors: Seung Yeol Lee, Hee-Jung Cheon, Sang Jun Kim, Young Mog Shim, Jae Ill Zo, Ji Hye Hwang

Published in: Supportive Care in Cancer | Issue 1/2016

Login to get access

Abstract

Purpose

The purposes of this study are to assess the usefulness of bedside swallowing tests and identify the clinical risk factors for subglottic aspiration after esophagectomy in esophageal cancer patients.

Methods

The study included patients who underwent esophagectomy for esophageal cancer between January and August 2013. Videofluoroscopic swallowing study (VFSS) was carried out 7 to 10 days post-surgery, and clinical bedside swallowing tests were conducted to determine the risk factors for subglottic aspiration.

Results

A total of 118 patients were evaluated, 38 of whom (32.2 %) showed evidence of subglottic aspiration on VFSS. The clinical bedside swallowing test yielded positive results in 26 of the 38 patients with subglottic aspiration (sensitivity 68.4 %). Prolonged operation time and vocal cord paralysis were risk factors predicting aspiration in multiple logistic regression analysis (odds ratio (OR), 0.651 per hour; P = 0.017 and OR, 9.1; P < 0.001). When operation times were divided into two groups, greater than or equal to 6 h (≥6 h) and less than 6 h (<6 h), the OR of operation time ≥6 h to aspiration was increased to 3.22 (P = 0.007).

Conclusions

We found that the clinical bedside swallowing test had a sensitivity of 68.4 %, which, without VFSS, was insufficient to detect subglottic aspiration. Operation time greater than or equal to 6 h and vocal cord paralysis were risk factors for subglottic aspiration. Therefore, VFSS should be recommended in esophageal cancer patients who have operation time greater than or equal to 6 h or have vocal cord paralysis after esophagectomy.
Literature
1.
go back to reference Law S, Wong J (2001) What is appropriate treatment for carcinoma of the thoracic esophagus? World J Surg 25:189–195CrossRefPubMed Law S, Wong J (2001) What is appropriate treatment for carcinoma of the thoracic esophagus? World J Surg 25:189–195CrossRefPubMed
2.
3.
go back to reference Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE (2002) Pulmonary complications after esophagectomy. Ann Thorac Surg 73:922–926CrossRefPubMed Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE (2002) Pulmonary complications after esophagectomy. Ann Thorac Surg 73:922–926CrossRefPubMed
4.
go back to reference Bailey SH, Bull DA, Harpole DH, Rentz JJ, Neumayer LA, Pappas TN, Daley J, Henderson WG, Krasnicka B, Khuri SF (2003) Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 75:217–222, discussion 222 CrossRefPubMed Bailey SH, Bull DA, Harpole DH, Rentz JJ, Neumayer LA, Pappas TN, Daley J, Henderson WG, Krasnicka B, Khuri SF (2003) Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 75:217–222, discussion 222 CrossRefPubMed
5.
go back to reference Yoshida N, Watanabe M, Baba Y, Iwagami S, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Ozaki N, Baba H (2013) Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today 44(3):526–532CrossRefPubMed Yoshida N, Watanabe M, Baba Y, Iwagami S, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Ozaki N, Baba H (2013) Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today 44(3):526–532CrossRefPubMed
6.
go back to reference Atkins BZ, Shah AS, Hutcheson KA, Mangum JH, Pappas TN, Harpole DH Jr, D’Amico TA (2004) Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 78:1170–1176, discussion 1170–1176 CrossRefPubMed Atkins BZ, Shah AS, Hutcheson KA, Mangum JH, Pappas TN, Harpole DH Jr, D’Amico TA (2004) Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 78:1170–1176, discussion 1170–1176 CrossRefPubMed
7.
go back to reference Berry MF, Atkins BZ, Tong BC, Harpole DH, D’Amico TA, Onaitis MW (2010) A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia. J Thorac Cardiovasc Surg 140:1266–1271PubMedCentralCrossRefPubMed Berry MF, Atkins BZ, Tong BC, Harpole DH, D’Amico TA, Onaitis MW (2010) A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia. J Thorac Cardiovasc Surg 140:1266–1271PubMedCentralCrossRefPubMed
8.
go back to reference Daniels SK, Ballo LA, Mahoney MC, Foundas AL (2000) Clinical predictors of dysphagia and aspiration risk: outcome measures in acute stroke patients. Arch Phys Med Rehabil 81:1030–1033CrossRefPubMed Daniels SK, Ballo LA, Mahoney MC, Foundas AL (2000) Clinical predictors of dysphagia and aspiration risk: outcome measures in acute stroke patients. Arch Phys Med Rehabil 81:1030–1033CrossRefPubMed
9.
go back to reference Ramsey DJ, Smithard DG, Kalra L (2003) Early assessments of dysphagia and aspiration risk in acute stroke patients. Stroke 34:1252–1257CrossRefPubMed Ramsey DJ, Smithard DG, Kalra L (2003) Early assessments of dysphagia and aspiration risk in acute stroke patients. Stroke 34:1252–1257CrossRefPubMed
10.
go back to reference Hulscher JB, van Sandick JW, Devriese PP, van Lanschot JJ, Obertop H (1999) Vocal cord paralysis after subtotal oesophagectomy. Br J Surg 86:1583–1587CrossRefPubMed Hulscher JB, van Sandick JW, Devriese PP, van Lanschot JJ, Obertop H (1999) Vocal cord paralysis after subtotal oesophagectomy. Br J Surg 86:1583–1587CrossRefPubMed
11.
go back to reference Gockel I, Kneist W, Keilmann A, Junginger T (2005) Recurrent laryngeal nerve paralysis (RLNP) following esophagectomy for carcinoma. Eur J Surg Oncol 31:277–281CrossRefPubMed Gockel I, Kneist W, Keilmann A, Junginger T (2005) Recurrent laryngeal nerve paralysis (RLNP) following esophagectomy for carcinoma. Eur J Surg Oncol 31:277–281CrossRefPubMed
12.
go back to reference Pierie JP, Goedegebuure S, Schuerman FA, Leguit P (2000) Relation between functional dysphagia and vocal cord palsy after transhiatal oesophagectomy. Eur J Surg 166:207–209CrossRefPubMed Pierie JP, Goedegebuure S, Schuerman FA, Leguit P (2000) Relation between functional dysphagia and vocal cord palsy after transhiatal oesophagectomy. Eur J Surg 166:207–209CrossRefPubMed
13.
go back to reference Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K (1998) Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 186:306–312CrossRefPubMed Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K (1998) Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 186:306–312CrossRefPubMed
14.
go back to reference Maffezzini M (2013) Words of Wisdom: re: trends in hospital volume and operative mortality for high-risk surgery. Eur Urol 63:582CrossRefPubMed Maffezzini M (2013) Words of Wisdom: re: trends in hospital volume and operative mortality for high-risk surgery. Eur Urol 63:582CrossRefPubMed
15.
go back to reference Perie S, Laccourreye O, Bou-Malhab F, Brasnu D (1998) Aspiration in unilateral recurrent laryngeal nerve paralysis after surgery. Am J Otolaryngol 19:18–23CrossRefPubMed Perie S, Laccourreye O, Bou-Malhab F, Brasnu D (1998) Aspiration in unilateral recurrent laryngeal nerve paralysis after surgery. Am J Otolaryngol 19:18–23CrossRefPubMed
16.
go back to reference Leder SB, Bayar S, Sasaki CT, Salem RR (2007) Fiberoptic endoscopic evaluation of swallowing in assessing aspiration after transhiatal esophagectomy. J Am Coll Surg 205:581–585CrossRefPubMed Leder SB, Bayar S, Sasaki CT, Salem RR (2007) Fiberoptic endoscopic evaluation of swallowing in assessing aspiration after transhiatal esophagectomy. J Am Coll Surg 205:581–585CrossRefPubMed
17.
go back to reference Easterling CS, Bousamra M 2nd, Lang IM, Kern MK, Nitschke T, Bardan E, Shaker R (2000) Pharyngeal dysphagia in postesophagectomy patients: correlation with deglutitive biomechanics. Ann Thorac Surg 69:989–992CrossRefPubMed Easterling CS, Bousamra M 2nd, Lang IM, Kern MK, Nitschke T, Bardan E, Shaker R (2000) Pharyngeal dysphagia in postesophagectomy patients: correlation with deglutitive biomechanics. Ann Thorac Surg 69:989–992CrossRefPubMed
18.
go back to reference Martin RE, Letsos P, Taves DH, Inculet RI, Johnston H, Preiksaitis HG (2001) Oropharyngeal dysphagia in esophageal cancer before and after transhiatal esophagectomy. Dysphagia 16:23–31CrossRefPubMed Martin RE, Letsos P, Taves DH, Inculet RI, Johnston H, Preiksaitis HG (2001) Oropharyngeal dysphagia in esophageal cancer before and after transhiatal esophagectomy. Dysphagia 16:23–31CrossRefPubMed
19.
go back to reference Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Doki Y (2013) Evaluation of dysphagia and diminished airway protection after three-field esophagectomy and a remedy. World J Surg 37:416–423CrossRefPubMed Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Doki Y (2013) Evaluation of dysphagia and diminished airway protection after three-field esophagectomy and a remedy. World J Surg 37:416–423CrossRefPubMed
20.
go back to reference Fang W, Kato H, Tachimori Y, Igaki H, Sato H, Daiko H (2003) Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer. Ann Thorac Surg 76:903–908CrossRefPubMed Fang W, Kato H, Tachimori Y, Igaki H, Sato H, Daiko H (2003) Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer. Ann Thorac Surg 76:903–908CrossRefPubMed
21.
go back to reference Langmore SE, Terpenning MS, Schork A, Chen Y, Murray JT, Lopatin D, Loesche WJ (1998) Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia 13:69–81CrossRefPubMed Langmore SE, Terpenning MS, Schork A, Chen Y, Murray JT, Lopatin D, Loesche WJ (1998) Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia 13:69–81CrossRefPubMed
Metadata
Title
Clinical predictors of aspiration after esophagectomy in esophageal cancer patients
Authors
Seung Yeol Lee
Hee-Jung Cheon
Sang Jun Kim
Young Mog Shim
Jae Ill Zo
Ji Hye Hwang
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2776-8

Other articles of this Issue 1/2016

Supportive Care in Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine